Retour

Alector to Participate in Upcoming Healthcare Conferences

Calendar Calendar of Events

SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:

GlobeNewswire Inc. • 09/05/2024 à 13:00:00
Alector, Inc. Common Stock
Address: 131 OYSTER POINT BLVD., SUITE 600
Postal Code: 94080
City: SOUTH SAN FRANCISCO
State: CA
Phone Number: 415-231-5660
Website: https://www.alector.com
Status: Active
Company Info

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

List Date2019-02-07
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001653087
Composite figiBBG00N0PL198
Share Class figiBBG00N0PL214
Market Cap524,332,017 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees244
Share Class Shares Outstanding96390000
Weighted Shares Outstanding96384562
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
5.445
5.485
5.65
5.33
5.395
Variance
-0.69%
-2.44%
6%
-1.2%
0.19%
Open
5.483
5.622
5.33
5.395
5.385
Highest
5.63
5.729
5.665
5.589
5.537
Lowest
5.63
5.695
5.663
5.585
5.53
History
PeriodVarhighestlowest
1 week
1.11%
5.537
5.53
1 month
6.87%
5.239
5.116
3 month
-10.22%
7.279
5.116
6 month
26.33%
4.97
4.28
1 year
-28.17%
7.81
3.66
3 year
-68.76%
17.75
3.66
5 year
-72.67%
20.2395
3.66
10 year
-70.88%
19.5
3.66
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Assets 748,342,000 708,737,000 672,395,000 UNPUB
Current Assets 686,002,000 647,992,000 613,147,000 UNPUB
Current Liabilities 99,300,000 132,270,000 155,402,000 UNPUB
Equity 183,015,000 196,306,000 162,555,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 183,015,000 196,306,000 162,555,000 UNPUB
Liabilities 565,327,000 512,431,000 509,840,000 UNPUB
Liabilities And Equity 748,342,000 708,737,000 672,395,000 UNPUB
Noncurrent Assets 62,340,000 60,745,000 59,248,000 UNPUB
Noncurrent Liabilities 466,027,000 380,161,000 354,438,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 41,232,000 -63,938,000 -29,579,000 UNPUB
Net Cash Flow, Continuing 41,232,000 -63,938,000 -29,579,000 UNPUB
Net Cash Flow From Financing Activities 1,079,000 881,000 0 UNPUB
Net Cash Flow From Financing Activities, Continuing 1,079,000 881,000 0 UNPUB
Net Cash Flow From Investing Activities 88,701,000 -21,815,000 16,961,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 88,701,000 -21,815,000 16,961,000 UNPUB
Net Cash Flow From Operating Activities -48,548,000 -43,004,000 -46,540,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -48,548,000 -43,004,000 -46,540,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Comprehensive Income/Loss -43,481,000 2,188,000 -43,810,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -43,481,000 2,188,000 -43,810,000 UNPUB
Other Comprehensive Income/Loss 2,376,000 2,188,000 -43,810,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent 2,376,000 813,000 665,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Basic Earnings Per Share -1 0 -1 UNPUB
Benefits Costs and Expenses 0 0 0 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 66,664,000 59,803,000 59,692,000 UNPUB
Diluted Earnings Per Share -1 0 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -45,857,000 1,375,000 -44,475,000 UNPUB
Income/Loss From Continuing Operations Before Tax 16,549,000 56,214,000 9,109,000 UNPUB
Income Tax Expense/Benefit 901,000 1,393,000 1,252,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -45,857,000 1,375,000 -44,475,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -45,857,000 1,375,000 -44,475,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -45,857,000 1,375,000 -44,475,000 UNPUB
Operating Expenses 66,664,000 59,803,000 59,692,000 UNPUB
Operating Income/Loss -50,115,000 -3,589,000 -50,583,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 16,549,000 56,214,000 9,109,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-08 2023-02-28
Assets UNPUB 889,672,000 837,038,000 787,648,000
Current Assets UNPUB 827,021,000 774,963,000 726,435,000
Current Liabilities UNPUB 149,409,000 160,889,000 93,809,000
Equity UNPUB 288,516,000 253,104,000 214,442,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 288,516,000 253,104,000 214,442,000
Liabilities UNPUB 601,156,000 583,934,000 573,206,000
Liabilities And Equity UNPUB 889,672,000 837,038,000 787,648,000
Noncurrent Assets UNPUB 62,651,000 62,075,000 61,213,000
Noncurrent Liabilities UNPUB 0 423,045,000 479,397,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-08 2023-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB 11,966,000 -174,829,000
Net Cash Flow, Continuing UNPUB UNPUB 11,966,000 -174,829,000
Net Cash Flow From Financing Activities UNPUB UNPUB 489,000 4,514,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 489,000 4,514,000
Net Cash Flow From Investing Activities UNPUB UNPUB 60,530,000 -159,014,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 60,530,000 -159,014,000
Net Cash Flow From Operating Activities UNPUB UNPUB -49,053,000 -20,329,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -49,053,000 -20,329,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-08 2023-02-28
Comprehensive Income/Loss UNPUB 9,883,000 -46,666,000 -136,942,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB 7,594,000 -46,666,000 -136,942,000
Other Comprehensive Income/Loss UNPUB 0 -46,666,000 -3,632,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB -2,289,000 -518,000 -3,632,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-08 2023-02-28
Basic Earnings Per Share UNPUB 0 -1 -2
Benefits Costs and Expenses UNPUB 0 0 0
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 70,376,000 62,600,000 271,451,000
Diluted Earnings Per Share UNPUB 0 -1 -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB 9,883,000 -46,148,000 -133,310,000
Income/Loss From Continuing Operations Before Tax UNPUB 9,883,000 14,852,000 133,617,000
Income Tax Expense/Benefit UNPUB 1,042,000 733,000 3,254,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB 9,883,000 -46,148,000 -133,310,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB 9,883,000 -46,148,000 -133,310,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB 9,883,000 -46,148,000 -133,310,000
Operating Expenses UNPUB 70,376,000 62,600,000 271,451,000
Operating Income/Loss UNPUB 9,475,000 -47,748,000 -137,834,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 79,851,000 14,852,000 133,617,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-04 2022-02-24
Assets 440,364,000 397,113,000 854,226,000 814,658,000
Current Assets 374,737,000 329,330,000 788,019,000 749,713,000
Current Liabilities 64,062,000 74,393,000 132,815,000 139,555,000
Equity 227,829,000 184,515,000 335,890,000 300,724,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 227,829,000 184,515,000 335,890,000 300,724,000
Liabilities 212,535,000 212,598,000 518,336,000 513,934,000
Liabilities And Equity 440,364,000 397,113,000 854,226,000 814,658,000
Noncurrent Assets 65,627,000 67,783,000 66,207,000 64,945,000
Noncurrent Liabilities 0 0 385,521,000 374,379,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-04 2022-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 60,734,000 15,010,000 390,819,000 279,183,000
Net Cash Flow, Continuing 60,734,000 15,010,000 390,819,000 279,183,000
Net Cash Flow From Financing Activities 3,874,000 2,962,000 14,821,000 30,295,000
Net Cash Flow From Financing Activities, Continuing 3,874,000 2,962,000 14,821,000 30,295,000
Net Cash Flow From Investing Activities 109,553,000 56,591,000 -69,054,000 -49,663,000
Net Cash Flow From Investing Activities, Continuing 109,553,000 56,591,000 -69,054,000 -49,663,000
Net Cash Flow From Operating Activities -52,693,000 -44,543,000 445,052,000 298,551,000
Net Cash Flow From Operating Activities, Continuing -52,693,000 -44,543,000 445,052,000 298,551,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-04 2022-02-24
Comprehensive Income/Loss -52,171,000 -55,147,000 126,353,000 -37,886,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -52,375,000 -55,354,000 126,353,000 -37,886,000
Other Comprehensive Income/Loss 0 0 126,353,000 -1,557,000
Other Comprehensive Income/Loss Attributable To Parent -204,000 -207,000 -244,000 -1,557,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-03 2021-11-04 2022-02-24
Basic Earnings Per Share UNPUB UNPUB 2 UNPUB
Benefits Costs and Expenses 56,281,000 0 0 243,414,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 56,281,000 61,893,000 56,084,000 243,414,000
Diluted Earnings Per Share UNPUB UNPUB 1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -52,171,000 -55,147,000 126,597,000 -36,329,000
Income/Loss From Continuing Operations Before Tax -52,171,000 -55,147,000 182,413,000 -36,329,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -52,171,000 -55,147,000 126,597,000 -36,329,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -52,171,000 -55,147,000 126,597,000 -36,329,000
Net Income/Loss Available To Common Stockholders, Basic -52,171,000 -55,147,000 126,597,000 -36,329,000
Operating Expenses 56,745,000 61,893,000 56,084,000 244,445,000
Operating Income/Loss -52,635,000 -55,325,000 126,329,000 -37,360,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 4,110,000 6,568,000 182,413,000 207,085,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-11 2020-11-10 2021-02-25
Assets 618,928,000 572,030,000 531,588,000 488,251,000
Current Assets 556,204,000 510,088,000 470,012,000 421,511,000
Current Liabilities 71,775,000 65,856,000 71,087,000 68,088,000
Equity 391,734,000 355,331,000 310,191,000 267,530,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 391,734,000 355,331,000 310,191,000 267,530,000
Liabilities 227,194,000 216,699,000 221,397,000 220,721,000
Liabilities And Equity 618,928,000 572,030,000 531,588,000 488,251,000
Noncurrent Assets 62,724,000 61,942,000 61,576,000 66,740,000
Noncurrent Liabilities 0 0 150,310,000 152,633,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-11 2020-11-10 2021-02-25
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 71,276,000 -68,416,000 -7,522,000 -39,672,000
Net Cash Flow, Continuing 71,276,000 -68,416,000 -7,522,000 -39,672,000
Net Cash Flow From Financing Activities 228,461,000 2,270,000 286,000 232,113,000
Net Cash Flow From Financing Activities, Continuing 228,461,000 2,270,000 286,000 232,113,000
Net Cash Flow From Investing Activities -124,872,000 -24,744,000 33,013,000 -105,051,000
Net Cash Flow From Investing Activities, Continuing -124,872,000 -24,744,000 33,013,000 -105,051,000
Net Cash Flow From Operating Activities -32,313,000 -45,942,000 -40,821,000 -166,734,000
Net Cash Flow From Operating Activities, Continuing -32,313,000 -45,942,000 -40,821,000 -166,734,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-11 2020-11-10 2021-02-25
Comprehensive Income/Loss -40,019,000 -45,326,000 -53,456,000 -189,756,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -37,379,000 -46,262,000 -53,456,000 -189,756,000
Other Comprehensive Income/Loss 0 0 -53,456,000 472,000
Other Comprehensive Income/Loss Attributable To Parent 2,640,000 -936,000 -752,000 472,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-11 2020-11-10 2021-02-25
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 47,190,000 0 0 211,326,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 47,190,000 49,759,000 59,653,000 211,326,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -40,019,000 -45,326,000 -52,704,000 -190,228,000
Income/Loss From Continuing Operations Before Tax -40,019,000 -45,326,000 5,904,000 -190,228,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -40,019,000 -45,326,000 -52,704,000 -190,228,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -40,019,000 -45,326,000 -52,704,000 -190,228,000
Net Income/Loss Available To Common Stockholders, Basic -40,019,000 -45,326,000 -52,704,000 -190,228,000
Operating Expenses 49,249,000 49,759,000 59,653,000 216,272,000
Operating Income/Loss -42,078,000 -46,589,000 -53,749,000 -195,174,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 7,171,000 3,170,000 5,904,000 21,098,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-12 2019-11-12 2020-03-24
Assets 496,044,000 477,251,000 449,730,000 421,913,000
Current Assets 442,114,000 414,597,000 385,483,000 357,437,000
Current Liabilities 55,834,000 67,102,000 58,718,000 61,970,000
Equity 266,186,000 245,716,000 218,587,000 194,743,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 266,186,000 245,716,000 218,587,000 194,743,000
Liabilities 229,858,000 231,535,000 231,143,000 227,170,000
Liabilities And Equity 496,044,000 477,251,000 449,730,000 421,913,000
Noncurrent Assets 53,930,000 62,654,000 64,247,000 64,476,000
Noncurrent Liabilities 0 0 172,425,000 165,200,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-12 2019-11-12 2020-03-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -4,516,000 8,254,000 17,766,000 24,171,000
Net Cash Flow, Continuing -4,516,000 8,254,000 17,766,000 24,171,000
Net Cash Flow From Financing Activities 170,312,000 -116,000 720,000 172,353,000
Net Cash Flow From Financing Activities, Continuing 170,312,000 -116,000 720,000 172,353,000
Net Cash Flow From Investing Activities -151,262,000 26,422,000 45,909,000 -48,874,000
Net Cash Flow From Investing Activities, Continuing -151,262,000 26,422,000 45,909,000 -48,874,000
Net Cash Flow From Operating Activities -23,566,000 -18,052,000 -28,863,000 -99,308,000
Net Cash Flow From Operating Activities, Continuing -23,566,000 -18,052,000 -28,863,000 -99,308,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-12 2019-11-12 2020-03-24
Comprehensive Income/Loss -18,560,000 -24,560,000 -31,738,000 -105,201,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -18,410,000 -24,227,000 -31,953,000 -105,201,000
Other Comprehensive Income/Loss 0 0 0 184,000
Other Comprehensive Income/Loss Attributable To Parent 150,000 333,000 -215,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-12 2019-11-12 2020-03-24
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 126,604,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 26,366,000 34,069,000 36,845,000 126,604,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -18,560,000 -24,560,000 -31,738,000 -105,385,000
Income/Loss From Continuing Operations Before Tax 5,605,000 6,917,000 2,696,000 -105,385,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -18,560,000 -24,560,000 -31,738,000 -105,385,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -18,560,000 -24,560,000 -31,738,000 -105,385,000
Net Income/Loss Available To Common Stockholders, Basic -18,560,000 -24,560,000 -31,738,000 -105,385,000
Operating Expenses 26,366,000 34,069,000 36,845,000 135,623,000
Operating Income/Loss -20,761,000 -27,152,000 -34,149,000 -114,404,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 5,605,000 6,917,000 2,696,000 21,219,000
Calendar
20 May 2024 (Time UTC) Actual Previous Consensus
★
10:30
United States
★★
09:00
United States
★★
09:00
United States
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-5400.000
-17800.000
★
15:30
United States
-66000.000
-60000.000
★
15:30
United States
59500.000
53700.000
★
15:30
United States
-116600.000
-135800.000
★★
15:30
United States
3200.000
4400.000
★
15:30
United States
203000.000
215400.000
★
15:30
United States
200.000
-31400.000
★
15:30
United States
61800.000
62600.000
★
15:30
United States
1300.000
1300.000
★
15:30
United States
-25300.000
-9700.000
★
15:30
United States
204500.000
199600.000
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:ALEC240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:ALEC240517P00010000 OPASPS Put American 100 10 BATO 2024-05-17
O:ALEC240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:ALEC240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:ALEC240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:ALEC240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:ALEC240517C00010000 OCASPS Call American 100 10 BATO 2024-05-17
O:ALEC240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:ALEC240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:ALEC240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:ALEC240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:ALEC240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:ALEC240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:ALEC240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:ALEC240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:ALEC240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:ALEC240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:ALEC240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:ALEC240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:ALEC240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:ALEC240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:ALEC240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:ALEC240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:ALEC240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:ALEC240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:ALEC240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:ALEC240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:ALEC240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:ALEC240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:ALEC240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:ALEC240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:ALEC240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:ALEC240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:ALEC240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:ALEC240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:ALEC240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:ALEC240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:ALEC240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:ALEC240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:ALEC240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:ALEC240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:ALEC240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:ALEC240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:ALEC240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:ALEC240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:ALEC240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:ALEC240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:ALEC240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:ALEC240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:ALEC240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:ALEC240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:ALEC240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:ALEC240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:ALEC240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:ALEC240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:ALEC240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:ALEC240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:ALEC240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:ALEC240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:ALEC240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:ALEC240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:ALEC240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:ALEC240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:ALEC240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:ALEC240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:ALEC240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:ALEC240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:ALEC240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:ALEC240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:ALEC240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:ALEC231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:ALEC231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:ALEC231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:ALEC231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:ALEC231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:ALEC231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:ALEC231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:ALEC231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:ALEC231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:ALEC231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:ALEC231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:ALEC231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:ALEC231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:ALEC231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:ALEC231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:ALEC231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:ALEC231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:ALEC231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:ALEC231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:ALEC231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:ALEC231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:ALEC231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:ALEC231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:ALEC231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:ALEC231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:ALEC231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:ALEC231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:ALEC231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:ALEC231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:ALEC231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:ALEC231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:ALEC231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:ALEC231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:ALEC231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:ALEC230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:ALEC230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:ALEC230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:ALEC230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:ALEC230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:ALEC230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:ALEC230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:ALEC230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:ALEC230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:ALEC230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:ALEC230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:ALEC230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:ALEC230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:ALEC230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:ALEC230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:ALEC230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:ALEC230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:ALEC230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:ALEC230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:ALEC230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:ALEC230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:ALEC230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Alector to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
Alector to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
Call Scheduled for Tuesday, February 27, 2024, at 4:30 p.m. ET/1:30 p.m. PT Call Scheduled for Tuesday, February 27, 2024, at 4:30 p.m. ET/1:30 p.m. PT
GlobeNewswire Inc. • 2mo ago
News News
Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • 2mo ago
News Clinical Study
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
The trial, being conducted in partnership with GSK, is expected to enroll approximately 282 patients globally The trial, being conducted in partnership with GSK, is expected to enroll approximately 282 patients globally
GlobeNewswire Inc. • 3mo ago
News News
Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?
Alector (ALEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Investment Research • 3mo ago
Health Health
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
-Latozinemab is the most advanced progranulin-elevating candidate in development for FTD-GRN and has now become the first investigational medicine to receive a Breakthrough Therapy Designation for the treatment of FTD-GRN-
GlobeNewswire Inc. • 3mo ago
News News
Alector (ALEC) Upgraded to Strong Buy: Here's What You Should Know
Alector (ALEC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • 3mo ago
Stocks Financing Agreements
Alector Announces Closing of Public Offering
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the closing of its underwritten public offering of shares of its common stock. Alector sold 10,869,566 shares of its common stock in the offering. Alector has granted the underwriter a 30-day option to purchase up to an additional 1,630,434 shares of its common stock. The gross proceeds to Alector from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are approximately $75 million.
GlobeNewswire Inc. • 4mo ago
News News
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday. Shares of SolarEdge Technologies, Inc. (NASDAQ: SEDG) fell during Wednesday’s session after Barclays downgraded the stock from Equal-Weight to Underweight and lowered its price target from $74 to $50. SolarEdge Technologies shares declined 5.4% to $68.91 on Wednesday. Here are some other big stocks recording losses in today’s session. Spirit Airlines, Inc. (NYSE: SAVE) shares dipped 24.1% to $6.01 on continued downward momentum after a federal judge blocked JetBlue Airways from acquiring the company. Calavo Growers, Inc. (NASDAQ: CVGW) fell 15.4% to $24.56. Calavo Growers delayed release of its fourth-quarter and FY23 financial results. Alector, Inc. (NASDAQ: ...
Benzinga • 4mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT